Source:http://linkedlifedata.com/resource/pubmed/id/17547833
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2007-6-5
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1534-4827
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
173-4
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
ADOPT: lessons from comparison of glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
|
| pubmed:publicationType |
Journal Article,
Comment
|